Wyndham-Ovolo deal adds five Ovolo hotels to the Wyndham network
The hotels are the Ovolo Central in Hong Kong plus four Australian properties: the Ovolo Nishi in Canberra, Ovolo South Yarra in Melbourne, Ovolo The Valley in Brisbane and Ovolo Woolloomooloo in Sydney.
All five will be integrated into Wyndham's sales, marketing and distribution platforms and join the Wyndham Rewards loyalty program, which grants them access to roughly 120 million members.
Wyndham said that the Ovolo Group will continue to own and manage the Ovolo brand while working with Wyndham "to unlock additional development opportunities throughout Asia Pacific."
Ovolo Group launched its upscale Ovolo Hotels concept in 2010, billing it as a design-focused and experiential boutique brand.
"Through our partnership with Wyndham, we're flipping the script to unlock bold new growth opportunities by franchising a lifestyle brand without diluting its DNA," said Ovolo Group chief of staff Shivang Jhunjhnuwala, adding that Wyndham's support will help the brand "grow with intention and impact."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Marriott's (NASDAQ:MAR) Q2 Sales Beat Estimates
Global hospitality company Marriott (NASDAQ:MAR) beat Wall Street's revenue expectations in Q2 CY2025, with sales up 4.7% year on year to $6.74 billion. Its non-GAAP profit of $2.65 per share was 1% above analysts' consensus estimates. Is now the time to buy Marriott? Find out in our full research report. Marriott (MAR) Q2 CY2025 Highlights: Revenue: $6.74 billion vs analyst estimates of $6.66 billion (4.7% year-on-year growth, 1.2% beat) Adjusted EPS: $2.65 vs analyst estimates of $2.62 (1% beat) Adjusted EBITDA: $1.22 billion vs analyst estimates of $1.38 billion (18% margin, 12% miss) Management reiterated its full-year Adjusted EPS guidance of $9.97 at the midpoint EBITDA guidance for the full year is $5.35 billion at the midpoint, in line with analyst expectations Operating Margin: 18.3%, in line with the same quarter last year RevPAR: $142.78 at quarter end, up 5.4% year on year Market Capitalization: $70.97 billion Company Overview Founded by J. Willard Marriott in 1927, Marriott International (NASDAQ:MAR) is a global hospitality company with a portfolio of over 7,000 properties and 30 brands, spanning 130+ countries and territories. Revenue Growth A company's long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Unfortunately, Marriott's 8.9% annualized revenue growth over the last five years was sluggish. This was below our standard for the consumer discretionary sector and is a rough starting point for our analysis. We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new property or trend. Marriott's recent performance shows its demand has slowed as its annualized revenue growth of 5.9% over the last two years was below its five-year trend. We can dig further into the company's revenue dynamics by analyzing its revenue per available room, which clocked in at $142.78 this quarter and is a key metric accounting for daily rates and occupancy levels. Over the last two years, Marriott's revenue per room averaged 3.8% year-on-year growth. Because this number is lower than its revenue growth, we can see its sales from other areas like restaurants, bars, and amenities outperformed its room bookings. This quarter, Marriott reported modest year-on-year revenue growth of 4.7% but beat Wall Street's estimates by 1.2%. Looking ahead, sell-side analysts expect revenue to grow 4.5% over the next 12 months, similar to its two-year rate. This projection doesn't excite us and suggests its products and services will face some demand challenges. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Operating Margin Marriott's operating margin might fluctuated slightly over the last 12 months but has generally stayed the same, averaging 15.5% over the last two years. This profitability was solid for a consumer discretionary business and shows it's an efficient company that manages its expenses well. In Q2, Marriott generated an operating margin profit margin of 18.3%, in line with the same quarter last year. This indicates the company's overall cost structure has been relatively stable. Earnings Per Share We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company's growth is profitable. Marriott's EPS grew at an astounding 29.5% compounded annual growth rate over the last five years, higher than its 8.9% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded. In Q2, Marriott reported adjusted EPS at $2.65, up from $2.50 in the same quarter last year. This print was close to analysts' estimates. Over the next 12 months, Wall Street expects Marriott's full-year EPS of $9.68 to grow 9.1%. Key Takeaways from Marriott's Q2 Results It was good to see Marriott narrowly top analysts' revenue expectations this quarter. On the other hand, its EBITDA missed and its EBITDA guidance for next quarter fell short of Wall Street's estimates. Overall, this quarter was mixed. The stock remained flat at $258.77 immediately after reporting. Should you buy the stock or not? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Verge
2 hours ago
- The Verge
Amazon is bringing its Starlink alternative to Australia next year
Amazon's unproven Project Kuiper satellites will be put to work next year, supplying internet access to rural Australians. The retail giant announced an agreement with Australia's state-owned National Broadband Network Company (NBN Co) on Tuesday to provide satellite internet to more than 300,000 eligible customers across the country by mid-2026. 'Australia's vast geography presents unique connectivity challenges that traditional infrastructure often can't overcome,' Joe Lathan, Project Kuiper's manager for Australia and New Zealand, said in the press release. 'This partnership with NBN Co represents our commitment to solving these challenges through innovation and collaboration.' This is the first major partnership announced for Project Kuiper, Amazon's attempt to take on SpaceX's Starlink service. While the latter already has more than 8,000 satellites in orbit, providing service to more than 100 countries, Project Kuiper is barely out of the gate by comparison, with 78 satellites launched to date. Amazon's next launch is scheduled for August 7th as it continues to build a planned constellation of 3,236 satellites. The NBN Co partnership may not be the first Project Kuiper service to launch, however. Amazon's website says it expects to begin 'delivering service to customers in late 2025,' though the company hasn't yet revealed where, or how much the service and consumer hardware will cost. Posts from this author will be added to your daily email digest and your homepage feed. See All by Jess Weatherbed Posts from this topic will be added to your daily email digest and your homepage feed. See All Amazon Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Science Posts from this topic will be added to your daily email digest and your homepage feed. See All Space Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech
Yahoo
2 hours ago
- Yahoo
Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia
Launch complements existing Tweed and Spectrum Therapeutics product portfolio SMITHS FALLS, Ontario, August 05, 2025--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has introduced its Canadian-grown 7ACRES brand in Australia, expanding the Company's medical cannabis offering with two high-THC sativa strains: Ultra Jack and Jack Frost. Ultra Jack, a cross of Ultra Sour and Jack Haze, is one of 7ACRES' top performing flower strains in the Canadian medical and adult-use cannabis markets. Jack Frost, a cross of White Widow and Cold Creek Kush, adds further genetic depth to the lineup. Both strains are initially available in 10g flower formats. "Adding 7ACRES to our Australian portfolio helps ensure patients and prescribers have access to a diverse range of high-quality flower options," said Andrew Bevan, SVP, Global Medical. "With recent improvements to our global supply chain, we're positioned to deliver these strains with consistent quality and reliable access to patients in Australia." "Global medical is one of Canopy Growth's largest commercial opportunities," said Luc Mongeau, Chief Executive Officer. "Our ability to scale high-quality production in Canada and reliably supply international markets remains a key strength as we expand our global medical platform." The introduction of 7ACRES complements Canopy Growth's existing presence in Australia, which includes Tweed flower products as well as Spectrum Therapeutics oils available in Red, Yellow, White, and Blue formulations. Together, this expanded medical portfolio reflects Canopy Growth's focus on building a scalable medical platform across international markets. About Canopy GrowthCanopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives. Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia. Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA, LLC ("Canopy USA"). Canopy USA's portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi‑state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian, Inc., a California-based producer of high-quality cannabis extracts and clean vape technology. At Canopy Growth, we're shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we're paving the way for a better understanding of all that cannabis can offer. For more information visit View source version on Contacts Alex ThomasDirector, Tyler BurnsDirector, Investor Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
